IP Library Granted Patent US 8,481,724
Granted Patent B2
US 8,481,724 · App. 13/625,552 · Granted Jul 9, 2013

Synthesis of 2,4-pyrimidinediamines

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,481,724
App. No.
13/625,552
Granted
Jul 9, 2013
Kind
B2
Abstract

Disclosed herein are methods for synthesizing 2,4-pyrimidinediamines as well as intermediates used therein.

Claims (15)

1. A process for preparing a compound of formula VI:

comprising contacting a compound of formula IV:

with a compound of formula V:

in the presence of an amide,

wherein:

R 3 and R 4 are each independently C 1 -C 6 alkyl; and

X is halogen;

under conditions suitable for forming a compound of formula VI.

2. The process of claim 1 , wherein the compound of formula V is di-tert-butyl chloromethyl phosphate:

3. The process of claim 1 , wherein the conditions sufficient to produce the compound of formula VI comprise:

(i) combining the compound of formula IV with the compound of formula V with a base in a polar solvent; and

(ii) washing a product obtained from (i) in an aqueous base solution.

4. The process of claim 3 , wherein the base in (i) comprises at least one of cesium carbonate (Cs 2 CO 3 ) and potassium carbonate (K 2 CO 3 ); the polar solvent comprises at least one of DMF and N,N-dimethylacetamide (DMAc); and the aqueous base in (ii) comprises at least one of sodium bicarbonate (NaHCO 3 ) and sodium hydroxide (NaOH).

5. The process of claim 1 , wherein the compound of formula VI is not isolated.

6. The process of claim 1 , wherein the compound of formula V is stabilized with N,N-dimethylacetamide (DMAc) solvent.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2026
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FUNDING IV TRUST
Reel/Frame 075576/0880 →
SECURITY INTEREST Recorded Aug 25, 2022
From: RIGEL PHARMACEUTICALS, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061327/0712 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 24, 2012
From: FELFER, ULFRIED; GISELBRECHT, KARL-HEINZ; WOLBERG, MICHAEL
To: RIGEL PHARMACEUTICALS, INC.
Reel/Frame 029014/0742 →